Z.HashemK
Plus, those who are pregnant or breastfeeding and those with digestive disorders, such as IBS or ulcerative colitis, should speak with their healthcare provider before using the product
Not surprisingly, Type 2 diabetes is a heterogeneous disease with multiple genetic abnormalities, said DeFronzo
Novo Nordisk (NVO) Trailing P/Es: LLY 38, NOV 10 Forward P/Es: LLY 26, NVO 11 Estimated 2026 sales growth: LLY 26%, NVO -8% Estimated 2025 EPS growth: LLY 43%, NVO -6% Cash per share: LLY $8.14, NVO $6.07 Institutional ownership: LLY 84.6%, NVO 9.5% In terms of value, NVO has LLY beat by a mile, trading at less than a third of LLY on a trailing price-to-earnings basis and just under half of it on a forward price-to-earnings basis
My goal was to lose 50 pounds by August but Im ok with that